BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/21/2026 5:59:39 AM | Browse: 5 | Download: 0
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Opinion Review |
| Article Title |
Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Antresa Jose, Abul Bashar Mohammad Kamrul-Hasan, Cornelius J Fernandez and Joseph M Pappachan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, FRCP, MD, MRCP, Professor, Senior Researcher, Faculty of Science,, Manchester Metropolitan University, Manchester, Manchester M15 6BH, Greater Manchester, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Diabetic kidney disease; Chronic kidney disease; Disease-modifying treatment; Mineralocorticoid receptor antagonists; Renin-angiotensin-aldosterone system |
| Core Tip |
Diabetic kidney disease (DKD) is a leading cause of morbidity and mortality in people with diabetes mellitus. Traditional disease-modifying treatments do not fully target the underlying mechanisms. The renin-angiotensin-aldosterone system is over activated and only partially suppressed by the renin-angiotensin-aldosterone system blockers like angiotensin- converting enzyme inhibitors or angiotensin II receptor blockers in the context of diabetic kidney disease (DKD). This article is based on the latest research evidence and discusses the relevant strategies for treating diabetic nephropathy patients. |
| Citation |
Jose A, Kamrul-Hasan ABM, Fernandez CJ, Pappachan JM. Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach. World J Nephrol 2026; In press |
 |
Received |
|
2026-02-24 06:05 |
 |
Peer-Review Started |
|
2026-02-24 06:05 |
 |
First Decision by Editorial Office Director |
|
2026-02-28 06:59 |
 |
Return for Revision |
|
2026-02-28 06:59 |
 |
Revised |
|
2026-03-05 09:30 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-04-21 02:51 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-21 05:59 |
 |
Articles in Press |
|
2026-04-21 05:59 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345